Reduction in Vial Size of Aducanumab Could Yield Savings
Savings would range from $70.9 to $369.0 million annually if the 300 mg/3.0 mL vial was reduced to 100 mg/1.0 mL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.